CVI Holdings’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
– Sell
-1,213
Closed -$991K – 73
2019
Q1
$991K Buy
+1,213
New +$980K 0.94% 17

Other funds holding MTNB

CVI Holdings's MTNB Position: Q2 2019 in Review

CVI Holdings sold out of Matinas BioPharma (MTNB) in Q2 2019, closing a stake of 1,213 shares — an estimated $991K sold.

CVI Holdings first reported a position in MTNB in Q1 2019 and held it in 1 quarter. The position peaked at $991K in Q1 2019. 45 funds tracked by Wall St. Rank hold MTNB as of Q2 2019.

  • CVI Holdings reported no remaining Matinas BioPharma position as of Q2 2019 after selling out during the quarter.
  • CVI Holdings sold 1,213 Matinas BioPharma shares in Q2 2019, an estimated $991K.
  • CVI Holdings first reported a position in Matinas BioPharma in Q1 2019 and held it in 1 quarter.
  • CVI Holdings's Matinas BioPharma position peaked at $991K in Q1 2019.
  • 45 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2019.

Based on CVI Holdings's 13F filing for Q2 2019, filed 14 Aug 2019.